HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

1- (4- ((4- (Dimethylamino)piperidin- 1- yl)carbonyl)phenyl)- 3- (4- (4,6- dimorpholin- 4- yl- 1,3,5- triazin- 2- yl)phenyl)urea

an mTOR inhibitor; structure in first source
Also Known As:
PKI 587; PKI-587; PKI587
Networked: 5 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Lin, Xiaoshan: 1 article (02/2015)
2. Chen, Longhua: 1 article (02/2015)
3. Wang, Wei: 1 article (02/2015)
4. Wang, Rong: 1 article (02/2015)
5. Li, Qi: 1 article (02/2015)
6. Yang, Hua: 1 article (02/2015)
7. Zhang, Yuqin: 1 article (02/2015)
8. Sun, Quanquan: 1 article (02/2015)
9. Xiao, Dong: 1 article (02/2015)
10. Yuan, Yawei: 1 article (02/2015)

Related Diseases

1. Neoplasms (Cancer)
2. Neurilemmoma (Schwannoma)
3. Liver Neoplasms (Liver Cancer)
4. Head and Neck Neoplasms (Head and Neck Cancer)
5. Glioma (Gliomas)

Related Drugs and Biologics

1. Threonine (L-Threonine)
2. Serine (L-Serine)
3. Type I DNA Topoisomerases (Topoisomerase I)
4. Nasopharyngeal carcinoma
5. PD 0325901
6. N- (4- (3- chloro- 4- (2- pyridinylmethoxy)anilino)- 3- cyano- 7- ethoxy- 6- quinolyl)- 4- (dimethylamino)- 2- butenamide
7. sorafenib (BAY 43-9006)
8. cetuximab (Erbitux)
9. irinotecan (Camptosar)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)